EP Patent

EP3903857A1 — Syringe for improved injection and aspiration

Assigned to Galderma Holding SA · Expires 2021-11-03 · 5y expired

What this patent protects

Syringe (1) with a tube (2), a plunger rod (3), and a plunger rod head (4). The plunger rod head (4) has a first surface (41) and a second surface (42). A finger grip component (5) is provided as a one-piece body attached to the tube (2), and includes an injection finger support …

USPTO Abstract

Syringe (1) with a tube (2), a plunger rod (3), and a plunger rod head (4). The plunger rod head (4) has a first surface (41) and a second surface (42). A finger grip component (5) is provided as a one-piece body attached to the tube (2), and includes an injection finger support surface (61) arched in a direction perpendicular to the longitudinal axis (A) with a first curvature for cooperative association with the first surface (41), and an aspiration finger support surface (62) arched in a direction perpendicular to the longitudinal axis (A) with a second curvature for cooperative association with the second surface (42).

Drugs covered by this patent

Patent Metadata

Patent number
EP3903857A1
Jurisdiction
EP
Classification
—
Expires
2021-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Galderma Holding SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.